Histology and Cell Biology Department, Faculty of Medicine, Tanta University, Egypt.
Histology and Cell Biology Department, Faculty of Medicine, Tanta University, Egypt.
Toxicology. 2021 Mar 30;452:152722. doi: 10.1016/j.tox.2021.152722. Epub 2021 Feb 13.
Aroclor 1254 is a mixture of polychlorinated biphenyls that are reported to disrupt thyroid hormone homeostasis, yet little is known on its effect on thyroid gland microarchitecture. Lycopene is a commonly used potent antioxidant. This study is a biochemical, histological, and immunohistochemical assessment of the effect of Aroclor 1254 on the morphology, proliferation, and angiogenesis of the thyroid gland in rat and to evaluate the possible ameliorating role of lycopene. Twenty-four adult male albino rats were divided into 4 groups; Control, lycopene-treated (4 mg/kg/day orally for 30 days), Aroclor 1254-treated (2 mg/kg/day intraperitoneally for 30 days), and lycopene & Aroclor 1254-treated group. Serum thyroid hormones, thyroid-stimulating hormone (TSH), and tissue malondialdehyde (MDA) were quantified. Thyroid specimens were processed for histological staining with hematoxylin and eosin, periodic acid-Schiff, and Mallory's trichrome stains as well as immunohistochemical staining for detection of calcitonin, Ki67, and VEGF. In this study, Aroclor 1254-treated animals recorded a significant decline in both serum T3 and T4 coupled with a significant elevation in both TSH and tissue MDA. Histological sections showed small irregular follicles with the formation of hyperplastic and micro follicles. Some follicular and parafollicular cells depicted nuclear and cytoplasmic alterations associating with scanty or absent colloid in addition to signs of inflammation and fibrosis. A significant upregulation in the immunohistochemical expression of calcitonin, Ki67, and VEGF was recorded. Lycopene co-treatment successfully reinstated the values of most studied parameters and retrieved a near-control thyroid morphology. In conclusion, Aroclor 1254 impacted the thyroid hormone homeostasis, morphology, proliferation, and angiogenesis of the thyroid gland in rat, while lycopene efficiently ameliorated these adverse effects.
Aroclor 1254 是一种多氯联苯混合物,据报道它会破坏甲状腺激素的内环境稳定,但对于其对甲状腺微结构的影响知之甚少。番茄红素是一种常用的强效抗氧化剂。本研究旨在评估 Aroclor 1254 对大鼠甲状腺形态、增殖和血管生成的影响,并研究番茄红素的可能改善作用,采用生化、组织学和免疫组织化学方法进行评估。将 24 只成年雄性白化大鼠分为 4 组:对照组、番茄红素处理组(每天口服 4mg/kg,连续 30 天)、Aroclor 1254 处理组(每天腹腔注射 2mg/kg,连续 30 天)和番茄红素+Aroclor 1254 处理组。测定血清甲状腺激素、促甲状腺激素(TSH)和组织丙二醛(MDA)。对甲状腺标本进行苏木精和伊红、过碘酸希夫(PAS)和马洛里三色染色以及降钙素、Ki67 和血管内皮生长因子(VEGF)免疫组织化学染色。在这项研究中,Aroclor 1254 处理组的大鼠血清 T3 和 T4 显著下降,同时 TSH 和组织 MDA 显著升高。组织学切片显示,甲状腺滤泡不规则,出现增生性和微小滤泡。一些滤泡和滤泡旁细胞出现核和细胞质改变,同时伴有胶体稀疏或缺如,以及炎症和纤维化迹象。降钙素、Ki67 和 VEGF 的免疫组织化学表达显著上调。番茄红素联合治疗成功地恢复了大多数研究参数的水平,并使甲状腺形态接近对照组。总之,Aroclor 1254 影响了大鼠甲状腺激素的内环境稳定、形态、增殖和血管生成,而番茄红素能有效改善这些不良反应。